Bisphosphonates (BPs) are highly effective in treating osteoporosis and reducing hip,
vertebral, and other fractures by as much as 50% to 70%. However, since 2006, atypical …

Osteoporosis and resulting osteoporotic fractures are responsible for significant morbidity,
excess mortality, and health care costs in the developed world. Medical therapy for …

Background: Atypical femoral fractures are the femoral fractures located anywhere between
the lesser trochanter and the supracondylar flare of the femur. Long-term bisphosphonates …

Background Atypical femur fractures are a rare occurrence, especially in bisphosphonate-
naïve men, and merit reporting owing to their unusual presentation and clinical implications …

This retrospective study investigates the prevalence of atypical femoral fractures (AFFs)
among patients admitted with hip and shaft fractures at a tertiary referral center in Beirut …

Introduction Initially endorsed as an antiosteoporotic agent, denosumab‒human
monoclonal antibody inhibiting the receptor activator of nuclear factor kappa-B ligand …

Bisphosphonates [BPs] are the mainstay for osteoporosis treatment. They suppress bone
resorption/remodeling, preventing bone loss. However, BPs also suppress the beneficial …

La sífilis congénita, es una infección sistémica provocada por la bacteria Treponema
pallidum, adquirida por el neonato vía transplacentaria de una madre que padece sífilis …

Background: Bisphosphonates are the most widely prescribed agents for the treatment of
postmenopausal osteoporosis and other metabolic bone diseases. Atypical femoral …

Background: Bisphosphonates are the most widely prescribed agents for the treatment of
postmenopausal osteoporosis and other metabolic bone diseases. Atypical femoral …